The cardiac health specialist announced FDA approval for one of its diagnostic products. It didn't hesitate to say the HeartFlow Plaque Analysis is now available for purchase. HeartFlow's ...

THOMASVILLE- According to the CDC, heart disease remains one of the leading causes of death in the United States, with over 800,000 heart attacks occurring annually. Coronary artery disease (CAD), the ...

HeartFlow has revealed plans to raise up to $300m in an initial public offering (IPO). The Bain Capital-backed AI-based coronary artery disease (CAD) platform developer filed a Form S-1 with the US ...

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of ...

The specialized healthcare diagnostics company earned two endorsements from heart health organizations. These concerned HeartFlow's plaque detection product. 10 stocks we like better than HeartFlow › ...

MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...

HeartFlow's market-moving announcement was that the U.S. Food and Drug Administration (FDA) granted approval for its HeartFlow Plaque Analysis algorithm. Following that, the company said the product ...

(MENAFN- GlobeNewsWire - Nasdaq) Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: ...